Showing results (341-350 of 356) with videos related to
Sort By:
Pageof 36
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumorsH Uematsu, N Sadato, T Ohtsubo, et al.International Journal of Oncology|June 15, 2000
Stromal sialyl Le(a) expression is correlated with vascular invasion of human gallbladder adenocarcinomaH Kijima, H Kashiwagi, S Dowaki, et al.Journal of Medicinal Chemistry|August 15, 1997
Synthesis, photophysical properties, in vivo photosensitizing efficacy, and human serum albumin binding properties of some novel bacteriochlorinsR K Pandey, S Constantine, T Tsuchida, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancerH Hatanaka, Y Abe, M Naruke, et al.International Journal of Oncology|February 17, 2000
DF3 expression in human gallbladder carcinoma: significance for lymphatic invasionH Kashiwagi, H Kijima, S Dowaki, et al.International Journal of Oncology|July 31, 1999
Stromal expression of thrombospondin-1 is correlated with growth and metastasis of human gallbladder carcinomaY Ohtani, H Kijima, S Dowaki, et al.International Journal of Oncology|February 17, 2001
Interleukin 10 expression is correlated with thrombospondin expression and decreased vascular involvement in colon cancerT Kawakami, T Tokunaga, H Hatanaka, et al.Endoscopy|September 16, 2000
Clinicopathological studies of esophageal carcinosarcoma: analyses of its morphological characteristics using endoscopic, histological, and immunohistochemical proceduresO Chino, H Kijima, H Shimada, et al.International Journal of Oncology|December 22, 1999
CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinomaS Dowaki, H Kijima, H Kashiwagi, et al.Melanoma Research|July 26, 2002
Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experienceK Wakamatsu, T Kageshita, M Furue, et al.Pageof 36